Latest Market Positioning News

Aroa Biosurgery has reported its first quarter of positive operating cash flow since listing on the ASX in 2020, alongside robust revenue growth projections and new regulatory approvals across key international markets.

Vinyl Group Ltd delivered a standout Q2 FY25 with a 172% jump in cash receipts and strategic acquisitions poised to boost earnings. The company’s international expansion and debt reduction efforts signal a transformative phase ahead.

Peel Mining has reported outstanding drilling results from its Wagga Tank project, revealing high-grade silver, copper, and gold mineralisation that extends the known resource and highlights significant exploration potential.

Aruma Resources advances its exploration portfolio with standout assay results at Fiery Creek and strategic leadership changes, setting the stage for upcoming drilling campaigns.

Accent Group Limited forecasts a solid $80 million EBIT for H1 FY25, driven by sales growth despite a challenging promotional environment squeezing margins. Strategic talks with Frasers Group signal potential long-term shifts.

Sarytogan Graphite Limited has secured a key mining license and demonstrated promising product applications, supported by a significant investment from the European Bank for Reconstruction and Development. The company is progressing towards customer qualification and offtake agreements while expanding exploration efforts.

Terrain Minerals has reopened its strategic placement to raise an additional $150,000 at a premium price, attracting a specialist micro-cap fund and reinforcing confidence in its gallium and base metals projects.

N1 Holdings Limited reports robust growth in revenue, EBITDA, and profitability for the December 2024 quarter, underpinned by disciplined risk management and a refined funding strategy.

Pinnacle has announced a teleconference on 5 February 2025 where its senior executives will discuss the half year FY2025 financial results and engage with investors and analysts.

Parabellum Resources reports a capital return from its Temarise investment and a strategic board reshuffle, while progressing exploration plans across its New South Wales projects.

Redcastle Resources has kicked off an extensive 8,500-metre drilling program across its Eastern Goldfields projects, supported by a recent $3.7 million capital raise and strategic licence acquisition.

TrivarX has secured positive feedback from the FDA on its pivotal trial design for MEB-001, an AI-driven algorithm targeting major depressive episode screening via sleep study data. The company is advancing site collaborations to launch a large-scale US trial.